BRCA2 and cancer: There is no age recommendation for RRM, but a firm recommendation to consider RRSO from 35 years of age for BRCA1 and 40 years of age for BRCA2. These recommendations were thus adequate in relation to the ages of cancer diagnoses in our cohort.